Evidence brief · Supplement

Boswellia for Osteoarthritis pain/function

Evidence grade B — Standardized extracts

Overall grade
Grade B
Last revised
1
graded outcome
0
references listed

Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.

1 at grade B — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • Osteoarthritis pain/functionEvidence grade B

    Standardized extracts

    Moderatemixed

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Studies disagree: Osteoarthritis pain/function (mixed agreement).

The evidence in words

The verdict

For osteoarthritis pain/function, Boswellia earns evidence grade B (moderate effect, mixed consistency) — there is real evidence here. Standardized extracts

How it might work

Boswellic acids inhibit 5-lipoxygenase and leukotriene synthesis, a distinct anti-inflammatory pathway from NSAIDs.

How to use it

100–250 mg/day of a high-AKBA standardized extract (product-dependent).

Safety & cautions

Well tolerated; occasional GI upset.

Bottom line

One of the more convincing joint botanicals for osteoarthritis pain. Use a standardized high-AKBA extract and give it a couple of weeks.

How it is used

As the entry records it, from the studies it summarises. Not a recommendation for you — doses that suit a trial population may not suit you.

Standard
100–250 mg/day high-AKBA extract.

Goes with

  • BoswelliaRead the full Boswellia monographEvidence grade B

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.

Last revised . A grade is this entry's reading of the evidence, not medical advice.